Effect of School HPV Vaccination Requirements on Pediatricians' Recommendations

Overview

Journal Vaccines (Basel)

Date 2025 Jan 8

PMID 39772037

Authors

Ashley Hedrick McKenzie

Lara S Savas

Ross Shegog

Dale S Mantey

Erica L Frost

Paul Gerardo Yeh

C Mary Healy

Stanley Spinner

L Aubree Shay

Sharice M Preston

Sally W Vernon

Affiliations

Soon will be listed here.

Abstract

: Pediatrician recommendations are highly influential in parents' decisions to vaccinate their children against HPV. Unqualified, presumptive, and bundled recommendations (UPBRs) are associated with increased HPV vaccine uptake and are considered best practice. This study analyzes pediatricians' self-reported data to assess changes in UPBR use and the psychosocial determinants of UPBR use as a result of the implementation of a multi-level intervention, the Adolescent Vaccination Program (AVP). : We surveyed pediatricians across 51 clinics in the Houston area. Baseline surveys ( = 137) were distributed in 2015, and follow-ups ( = 120) in 2019. : Pediatrician UPBR use significantly increased as a result of AVP implementation. Change in the provider belief that it is necessary to tell parents that HPV vaccination is not required for public school attendance significantly predicted UPBR use at follow up. This belief was also a significant mediator of increased use of UPBRs at follow-up. : AVP was successful in increasing pediatricians' use of UPBRs. Change in UPBR use is related to one critical psychosocial determinant: beliefs about communication regarding the non-mandatory nature of HPV vaccination for school enrollment. HPV vaccine promotion efforts should devote focus to changing pediatricians' beliefs about the necessity of disclosing the non-mandatory nature of HPV vaccination for school attendance.

References

Efua Sackey M, Markey K, Grealish A . Healthcare professional's promotional strategies in improving Human papillomavirus (HPV) vaccination uptake in adolescents: A systematic review. Vaccine. 2022; 40(19):2656-2666. DOI: 10.1016/j.vaccine.2022.03.054. View

Bland J, Altman D . Multiple significance tests: the Bonferroni method. BMJ. 1995; 310(6973):170. PMC: 2548561. DOI: 10.1136/bmj.310.6973.170. View

Rodriguez A, Do T, Goodman M, Schmeler K, Kaul S, Kuo Y . Human Papillomavirus Vaccine Interventions in the U.S.: A Systematic Review and Meta-analysis. Am J Prev Med. 2019; 56(4):591-602. DOI: 10.1016/j.amepre.2018.10.033. View

Feemster K, Winters S, Fiks A, Kinsman S, Kahn J . Pediatricians' intention to recommend human papillomavirus (HPV) vaccines to 11- to 12-year-old girls postlicensing. J Adolesc Health. 2008; 43(4):408-11. DOI: 10.1016/j.jadohealth.2008.06.012. View

Gilkey M, Malo T, Shah P, Hall M, Brewer N . Quality of physician communication about human papillomavirus vaccine: findings from a national survey. Cancer Epidemiol Biomarkers Prev. 2015; 24(11):1673-9. PMC: 4633386. DOI: 10.1158/1055-9965.EPI-15-0326. View

Kempe A, OLeary S, Markowitz L, Crane L, Hurley L, Brtnikova M . HPV Vaccine Delivery Practices by Primary Care Physicians. Pediatrics. 2019; 144(4). PMC: 8297056. DOI: 10.1542/peds.2019-1475. View

Vadaparampil S, Kahn J, Salmon D, Lee J, Quinn G, Roetzheim R . Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited. Vaccine. 2011; 29(47):8634-41. PMC: 3200426. DOI: 10.1016/j.vaccine.2011.09.006. View

Brewer N, Mitchell C, Alton Dailey S, Hora L, Fisher-Borne M, Tichy K . HPV vaccine communication training in healthcare systems: Evaluating a train-the-trainer model. Vaccine. 2021; 39(28):3731-3736. DOI: 10.1016/j.vaccine.2021.05.038. View

Cataldi J, OLeary S, Markowitz L, Allison M, Crane L, Hurley L . Changes in Strength of Recommendation and Perceived Barriers to Human Papillomavirus Vaccination: Longitudinal Analysis of Primary Care Physicians, 2008-2018. J Pediatr. 2021; 234:149-157.e3. PMC: 10207027. DOI: 10.1016/j.jpeds.2021.03.002. View

10.

Singh P, Dhalaria P, Kashyap S, Soni G, Nandi P, Ghosh S . Strategies to overcome vaccine hesitancy: a systematic review. Syst Rev. 2022; 11(1):78. PMC: 9044888. DOI: 10.1186/s13643-022-01941-4. View

11.

Meites E, Kempe A, Markowitz L . Use of a 2-Dose Schedule for Human Papillomavirus Vaccination - Updated Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2016; 65(49):1405-1408. DOI: 10.15585/mmwr.mm6549a5. View

12.

Allison M, Dunne E, Markowitz L, OLeary S, Crane L, Hurley L . HPV vaccination of boys in primary care practices. Acad Pediatr. 2013; 13(5):466-74. PMC: 5848092. DOI: 10.1016/j.acap.2013.03.006. View

13.

Nelson D, Kreps G, Hesse B, Croyle R, Willis G, Arora N . The Health Information National Trends Survey (HINTS): development, design, and dissemination. J Health Commun. 2004; 9(5):443-60. DOI: 10.1080/10810730490504233. View

14.

Pingali C, Yankey D, Elam-Evans L, Markowitz L, Valier M, Fredua B . National Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2021. MMWR Morb Mortal Wkly Rep. 2022; 71(35):1101-1108. PMC: 9472778. DOI: 10.15585/mmwr.mm7135a1. View

15.

Healy C, Savas L, Shegog R, Lunstroth R, Vernon S . Medical ethics principles underscore advocating for human papillomavirus vaccine. Hum Vaccin Immunother. 2022; 18(1):1989926. PMC: 9009910. DOI: 10.1080/21645515.2021.1989926. View

16.

Tsui J, Vincent A, Anuforo B, Btoush R, Crabtree B . Understanding primary care physician perspectives on recommending HPV vaccination and addressing vaccine hesitancy. Hum Vaccin Immunother. 2021; 17(7):1961-1967. PMC: 8189098. DOI: 10.1080/21645515.2020.1854603. View

17.

Opel D, Heritage J, Taylor J, Mangione-Smith R, Salas H, DeVere V . The architecture of provider-parent vaccine discussions at health supervision visits. Pediatrics. 2013; 132(6):1037-46. PMC: 3838535. DOI: 10.1542/peds.2013-2037. View

18.

Topazian H, Kundu D, Peebles K, Ramos S, Morgan K, Kim C . HPV Vaccination Recommendation Practices among Adolescent Health Care Providers in 5 Countries. J Pediatr Adolesc Gynecol. 2018; 31(6):575-582.e2. DOI: 10.1016/j.jpag.2018.06.010. View

19.

Brewer N, Hall M, Malo T, Gilkey M, Quinn B, Lathren C . Announcements Versus Conversations to Improve HPV Vaccination Coverage: A Randomized Trial. Pediatrics. 2016; 139(1). PMC: 5192091. DOI: 10.1542/peds.2016-1764. View

20.

Kreisel K, Spicknall I, Gargano J, Lewis F, Lewis R, Markowitz L . Sexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2018. Sex Transm Dis. 2021; 48(4):208-214. PMC: 10245608. DOI: 10.1097/OLQ.0000000000001355. View